Development and selection of marginal zone B cells

Immunological Reviews

Volumn 197, Issue , 2004, Pages 192-205

  Lopes Carvalho, Thiago ^a   Kearney, John F ^a,b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY RESPONSE; AUTOIMMUNITY; B LYMPHOCYTE; BLOOD FLOW; CELL MATURATION; HOMEOSTASIS; HUMAN; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPLEEN; SPLEEN CELL;

ANIMALS; AUTOIMMUNITY; B-LYMPHOCYTE SUBSETS; CELL LINEAGE; HUMANS; LYMPHOID TISSUE; MICE; SPLEEN; T-LYMPHOCYTES;

EID: 0942268727     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2004.0112.x     Document Type: Review

References (148)

1. Bendelac A, Bonneville M, Kearney JF. Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol 2001;1: 177-186.
2. Kraal G. Cells in the marginal zone of the spleen. Int Rev Cytol 1992;132:31-74.
3. Gu H et al. Most peripheral B cells in mice are ligand selected. J Exp Med 1991;173: 1357-1371.
4. Hayakawa K, et al. Positive selection of natural autoreactive B cells. Science 1999;285:113-116.
5. Martin F, Kearney JF. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 2000;12:39-49.
6. Julien S, et al. B cell positive selection by soluble self-antigen. J Immunol 2002; 169:4198-4204.
7. Holmberg D, et al. The repertoire of naturally activated B cells suggests the functionality of the idiotypic network. Ann Inst Pasteur Immunol 1986;137C:85-87.
8. Holmberg D, et al. The high idiotypic connectivity of 'natural' newborn antibodies is not found in adult mitogen-reactive B cell repertoires. Eur J Immunol 1986;16:82-87.
9. Holmberg D, et al. Establishment and functional implications of B-cell connectivity. Immunol Rev 1989;110:89-103.
10. Vakil M, Kearney JF. Functional characterization of monoclonal auto-antiidiotype antibodies isolated from the early B cell repertoire of BALB/ c mice. Eur J Immunol 1986;16:1151-1158.
11. Jerne NK. Towards a network theory of the immune system. Ann Immunol (Paris) 1974;125C:373-389.
12. Kelsoe G, Reth M, Rajewsky K. Control idiotope expression by monoclonal anti-idiotope antibodies. Immunol Rev 1980;52:75-88.
13. Kearney JF, Pollok BA, Stohrer R. Analysis of idiotypic heterogeneity in the anti-alpha 1-3 dextran and anti-phosphorylcholine responses using monoclonal anti-idiotype antibodies. Ann NY Acad Sci 1983;418: 151-170.
14. Kearney JF, Vakil M. Idiotype-directed interactions during ontogeny play a major role in the establishment of the adult B cell repertoire. Immunol Rev 1986;94:39-50.
15. Chen X, et al. Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int Immunol 1997;9:27-41.
16. Baker N, Ehrenstein MR. Cutting edge: selection of B lymphocyte subsets is regulated by natural IgM. J Immunol 2002;169: 6686-6690.
17. Freitas AA, et al. Normal serum immunoglobulins participate in the selection of peripheral B-cell repertoires. Proc Natl Acad Sci USA 1991;88:5640-5644.
18. Kim SJ, et al. I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med 2002;196:655-665.
19. Napirei M, et al. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 2000;25:177-181.
20. Botto M, et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998;19:56-59.
21. Hu L, et al. T15-idiotype-negative B cells dominate the phosphocholine binding cells in the preimmune repertoire of T15i knockin mice. J Immunol 2002;168:1273-1280.
22. Oliver AM, et al. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol 1997;27:2366-2674.
23. high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol 1999;162:7198-7207.
24. Ichiyoshi Y, Casali P. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. J Exp Med 1994;180:885-895.
25. Crouzier R, Martin T, Pasquali JL. Heavy chain variable region, light chain variable region, and heavy chain CDR3 influences on the mono-and polyreactivity and on the affinity of human monoclonal rheumatoid factors. J Immunol 1995;154:4526-4535.
26. Ten Boekel E, Melchers F, Rolink AG. Changes in the V(H) gene repertoire of developing precursor B lymphocytes in mouse bone marrow mediated by the pre-B cell receptor. Immunity 1997;7:357-368.
27. Dighiero G, et al. High frequency of natural autoantibodies in normal newborn mice. J Immunol 1985;134:765-771.
28. Leadbetter EA, et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002;416:603-607.
29. Youd ME, Ferguson AR, Corley RB. Synergistic roles of IgM and complement in antigen trapping and follicular localization. Eur J Immunol 2002;32:2328-2337.
30. Andersson J, Bullock WW, Melchers F. Inhibition of mitogenic stimulation of mouse lymphocytes by anti-mouse immunoglobulin antibodies. I. Mode of action. Eur J Immunol 1974;4:715-722.
31. Lawton AR III, Cooper MD. Modification of B lymphocyte differentiation by anti-immunoglobulins. Contemp Top Immunobiology 1974;3:193-225.
32. Rui L, et al. Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling. Nat Immun 2003;4:594-600.
33. Kearney JF, Cooper MD, Lawton AR. B lymphocyte differentiation induced by lipopolysaccharide. III. Suppression of B cell maturation by anti-mouse immunoglobulin antibodies. J Immunol 1976;116: 1664-1668.
34. Bernasconi NL, Onai N, Lanzavecchia A. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 2003;101:4500-4504.
35. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002;298:2199-2202.
36. Martin F, Kearney JF. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a 'natural immune memory'. Immunol Rev 2000;175:70-79.
37. + B cells both in vivo and in vitro. J Immunol 2000;164:4586-4593.
38. Shaw PX, et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 2000;105: 1731-1740.
39. Fagarasan S, Honjo T. T-independent immune response: new aspects of B cell biology. Science 2000;290:89-92.
40. Lam KP, Kuhn R, Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 1997;90:1073-1083.
41. Rosado MM, Freitas AA. The role of the B cell receptor V region in peripheral B cell survival. Eur J Immunol 1998;28:2685-2693.
42. Carvalho TL, et al. Arrested B lymphopoiesis and persistence of activated B cells in adult interleukin 7 (-/)-mice. J Exp Med 2001;194:1141-1150.
43. Hao Z, Rajewsky K. Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J Exp Med 2001;194:1151-1164.
44. Vosshenrich CA, et al. Thymic stromal-derived lymphopoietin distinguishes fetal from adult B cell development. Nat Immun 2003;4:773-779.
45. Lu LS, et al. Identification of a germ-line proB cell subset that distinguishes the fetal/neonatal from the adult B cell development pathway. Proc Natl Acad Sci USA 2002;99:3007-3012.
46. Ceredig R, et al. In interleukin-7-transgenic mice, increasing B lymphopoiesis increases follicular but not marginal zone B cell numbers. Eur J Immunol 2003;33: 2567-2576.
47. Dammers PM, et al. Most marginal zone B cells in rat express germline encoded Ig VH genes and are ligand selected. J Immunol 2000;165:6156-6169.
48. Forni L, et al. IgM antibodies induce the production of antibodies of the same specificity. Proc Natl Acad Sci USA 1980;77:1125-1128.
49. Vakil M, et al. In vivo suppression of perinatal multispecific B cells results in a distortion of the adult B cell repertoire. Eur J Immunol 1986;16:1159-1165.
50. Perlmutter RM, et al. Developmentally controlled expression of immunoglobulin VH genes. Science 1985;227:1597-1601.
51. Yancopoulos GD, Malynn BA, Alt FW. Developmentally regulated and strain-specific expression of murine VH gene families. J Exp Med 1988;168:417-435.
52. Carlsson L, Overmo C, Holmberg D. Selection against N-region diversity in immunoglobulin heavy chain variable regions during the development of preimmune B cell repertoires. Int Immunol 1992;4:549-553.
53. Carlsson L, Overmo C, Holmberg D. Developmentally controlled selection of antibody genes: characterization of individual VH7183 genes and evidence for stage-specific somatic diversification. Eur J Immunol 1992;22:71-78.
54. Niiro H, Clark EA. Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol 2002;2:945-956.
55. Cariappa A, Pillai S. Antigen-dependent B-cell development. Curr Opin Immunol 2002; 14:241-249.
56. Rickert RC, Rajewsky K, Roes J. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 1995;376:352-355.
57. Cariappa A, et al. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 2001;14:603-615.
58. Samardzic T, et al. Reduction of marginal zone B cells in CD22-deficient mice. Eur J Immunol 2002;32:561-567.
59. Seo S, Buckler J, Erikson J. Novel roles for Lyn in B cell migration and lipopolysaccharide responsiveness revealed using anti-double-stranded DNA Ig transgenic mice. J Immunol 2001;166:3710-3716.
60. Samardzic T, et al. BOB.1/OBF.1 deficiency affects marginal-zone B-cell compartment. Mol Cell Biol 2002;22:8320-8331.
61. Dalwadi H, et al. B cell developmental requirement for the G alpha i2 gene. J Immunol 2003;170:1707-1715.
62. Guinamard R, et al. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat Immun 2000;1:31-36.
63. Danzer CP, et al. Transitional and marginal zone B cells have a high proportion of unmasked CD22: implications for BCR signaling. Int Immunol 2003;15:1137-1147.
64. Dammers PM, et al. The origin of marginal zone B cells in the rat. Eur J Immunol 1999;29:1522-1531.
65. Loder F, et al. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med 1999;190:75-89.
66. Lo CG, Lu TT, Cyster JG. Integrin-dependence of lymphocyte entry into the splenic white pulp. J Exp Med 2003;197:353-361.
67. Lu TT, Cyster JG. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 2002;297:409-412.
68. Fukui Y, et al. Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature 2001; 412:826-831.
69. Croker BA, et al. The Rac2 guanosine triphosphatase regulates B lymphocyte antigen receptor responses and chemotaxis and is required for establishment of B-1a and marginal zone B lymphocytes. J Immunol 2002;168:3376-3386.
70. Girkontaite I, et al. Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat Immun 2001;2:855-862.
71. Won WJ, Kearney JF. CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J Immunol 2002;168: 5605-5611.
72. Kabarowski JH, et al. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science 2001;293:702-705.
73. Kabarowski JH, Xu Y, Witte ON. Lysophosphatidylcholine as a ligand for immunoregulation. Biochem Pharmacol 2002;64:161-167.
74. high B cells: a population of mixed origin. Eur J Immunol 1999;29:3285-3294.
75. Kumararatne DS, MacLennan IC. Cells of the marginal zone of the spleen are lymphocytes derived from recirculating precursors. Eur J Immunol 1981;11:865-869.
76. Tanigaki K, et al. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat Immun 2002;3:443-450.
77. Radtke F, et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 1999;10:547-558.
78. Jaleco AC, et al. Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation. J Exp Med 2001;194:991-1002.
79. Kuroda K, et al. Regulation of marginal zone B cell development by MINT, a suppressor of Notch/RBP-J signaling pathway. Immunity 2003;18:301-312.
80. Saito T, et al. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity 2003;18:675-685.
81. Witt CM, et al. Notch2 haploinsufficiency results in diminished B1 B cells and a severe reduction in marginal zone B cells. J Immunol 2003;171:2783-2788.
82. Oldfield S, et al. Memory B cells generated in T cell-dependent antibody responses colonise the splenic marginal zone. Adv Exp Med Biol 1988;237:93-98.
83. Liu YJ, et al. Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol 1991;21:2951-2962.
84. Pape KA, et al. Visualization of the genesis and fate of isotype-switched B cells during a primary immune response. J Exp Med 2003;197:1677-1687.
85. Dunn-Walters DK, Isaacson PG, Spencer J. Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. J Exp Med 1995;182:559-566.
86. Tierens A, et al. Mutation analysis of the rearranged immunoglobulin heavy chain genes of marginal zone cell lymphomas indicates an origin from different marginal zone B lymphocyte subsets. Blood 1998;91:2381-2386.
87. Tierens A, et al. Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion. Blood 1999;93:226-234.
88. Kumararatne DS, Bazin H, MacLennan IC. Marginal zones: the major B cell compartment of rat spleens. Eur J Immunol 1981;11:858-864.
89. Shih TA, et al. Role of BCR affinity in T cell dependent antibody responses in vivo. Nat Immun 2002;3:570-575.
90. Vinuesa CG, et al. Recirculating and germinal center B cells differentiate into cells responsive to polysaccharide antigens. Eur J Immunol 2003;33:297-305.
91. Schiemann B, et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 2001;293:2111-2114.
92. Batten M, et al. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 2000;192:1453-1466.
93. Balazs M, et al. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 2002;17:341-352.
94. Eloranta ML, Alm GV. Splenic marginal metallophilic macrophages and marginal zone macrophages are the major interferon-alpha/beta producers in mice upon intravenous challenge with herpes simplex virus. Scand J Immunol 1999;49:391-394.
95. Barchet W, et al. Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo. J Exp Med 2002;195:507-516.
96. Braun D, Caramalho I, Demengeot J. IFN-alpha/beta enhances BCR-dependent B cell responses. Int Immunol 2002;14:411-419.
97. Vasconcellos R, et al. Type I IFN sets the stringency of B cell repertoire selection in the bone marrow. Int Immunol 1999;11: 279-288.
98. Karlsson MC, et al. Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J Exp Med 2003;198:333-340.
99. Aichele P, et al. Macrophages of the splenic marginal zone are essential for trapping of blood-borne particulate antigen but dispensable for induction of specific T cell responses. J Immunol 2003;171:1148-1155.
100. Amano M, et al. CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: beta 2-microglobulin-dependent and independent forms. J Immunol 1998;161:1710-1717.
101. Roark JH, et al. CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J Immunol 1998;160:3121-3127.
102. + T lymphocytes. Science 1995; 268:863-865.
103. Schofield L, et al. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 1999;283:225-229.
104. Ochsenbein AF, et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 1999;286: 2156-2159.
105. Boes M, et al. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 1998;188:2381-2386.
106. Reid RR, et al. Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. J Immunol 1997;159:970-975.
107. Hayakawa K, et al. Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci USA 1984;81:2494-2498.
108. Ansel KM, Harris RB, Cyster JG. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 2002;16:67-76.
109. Forster I, Rajewsky K. Expansion and functional activity of Ly-1+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur J Immunol 1987;17:521-528.
110. Agenes F, Freitas AA. Transfer of small resting B cells into immunodeficient hosts results in the selection of a self-renewing activated B cell population. J Exp Med 1999;189:319-330.
111. Grandien A, et al. Positive and negative selection of antibody repertoires during B-cell differentiation. Immunol Rev 1994;137:53-89.
112. Nobrega A, et al. Regeneration of natural antibody repertoire after massive ablation of lymphoid system: robust selection mechanisms preserve antigen binding specificities. J Immunol 2002;169:2971-2978.
113. Cooper MD, et al. Development and function of the immunoglobulin producing system. I. Effect of bursectomy at different stages of development on germinal centers, plasma cells, immunoglobulins and antibody production. Int Arch Allergy Appl Immunol 1969;35:242-252.
114. Barreto V, Marques R, Demengeot J. Early death and severe lymphopenia caused by ubiquitous expression of the Rag1 and Rag2 genes in mice. Eur J Immunol 2001; 31:3763-3772.
115. Bosma GC, et al. Evidence of functional lymphocytes in some (leaky) scid mice. J Exp Med 1988;167:1016-1033.
116. Johnson GR, Carlisle HN, Saslaw S. Response of splenectomized mice to bacterial agents. Proc Soc Exp Biol Med 1967;126:298-300.
117. Shinefield HR, Steinberg CR, Kaye D. Effect of splenectomy on the susceptibility of mice inoculated with Diplococcus pneumoniae. J Exp Med 1966;123:777-794.
118. Hosea SW, et al. Impaired immune response of splenectomised patients to polyvalent pneumococcal vaccine. Lancet 1981;1: 804-807.
119. Overturf GD. Pneumococcal vaccination of children. Semin Pediatr Infect Dis 2002; 13:155-164.
120. Wardemann H, et al. B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J Exp Med 2002;195:771-780.
121. Dijkstra CD, et al. Marginal zone macrophages identified by a monoclonal antibody: characterization of immuno-and enzyme-histochemical properties and functional capacities. Immunology 1985;55:23-30.
122. Chao D, MacPherson GG. Analysis of thymus-independent type 2 antigen uptake by marginal zone macrophages in thin slices of viable lymphoid tissue in vitro. Eur J Immunol 1990;20:1451-1455.
123. Gray D, et al. Marginal zone B cells express CR1 and CR2 receptors. Eur J Immunol 1984;14:47-52.
124. Hayakawa K, Hardy RR, Herzenberg LA. Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J Exp Med 1985;161:1554-1568.
125. Benedict CL, Kearney JF. Increased junctional diversity in fetal B cells results in a loss of protective anti-phosphorylcholine antibodies in adult mice. Immunity 1999;10:607-617.
126. Masmoudi H, et al. All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes. Int Immunol 1990;2:515-520.
127. Jego G, et al. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 2003;19:225-234.
128. Wykes M, et al. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J Immunol 1998;161:1313-1319.
129. Litinskiy MB, et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immun 2002;3:822-829.
130. Crotty S, et al. SAP is required for generating long-term humoral immunity. Nature 2003;421:282-287.
131. Li Y, Li H, Weigert M. Autoreactive B cells in the marginal zone that express dual receptors. J Exp Med 2002;195:181-188.
132. Li Y, et al. Anti-DNA B cells in MRL/lpr mice show altered differentiation and editing pattern. J Exp Med 2002;196: 1543-1552.
133. Kenny JJ, et al. Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors. J Immunol 2000; 164:4111-4119.
134. Lam KP, Rajewsky K. B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development. J Exp Med 1999;190:471-477.
135. Zeng D, et al. Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice. J Immunol 2000;164:5000-5004.
136. Lane PJ, et al. Differences to the recruitment of virgin B cells into antibody responses to thymus-dependent and thymus-independent type-2 antigens. Eur J Immunol 1986;16:1569-1575.
137. Shlomchik MJ, et al. The role of clonal selection and somatic mutation in autoimmunity. Nature 1987;328:805-811.
138. Wither JE, Paterson AD, Vukusic B. Genetic dissection of B cell traits in New Zealand black mice. The expanded population of B cells expressing up-regulated costimulatory molecules shows linkage to Nba2. Eur J Immunol 2000;30:356-365.
139. Chan O, Shlomchik MJ. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation to MRL-lpr/lpr mice. J Immunol 1998;160:51-59.
140. Shlomchik M, et al. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med 1990;171:265-292.
141. William J, et al. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 2002;297:2066-2070.
142. Potter PK, et al. Lupus-prone mice have an abnormal response to thioglycolate and an impaired clearance of apoptotic cells. J Immunol 2003;170:3223-3232.
143. Santiago-Raber ML, et al. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J Exp Med 2003;197:777-788.
144. Braun D, Geraldes P, Demengeot J. Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice. J Autoimmun 2003;20:15-25.
145. Bennett L, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003;197:711-723.
146. Bondanza A, et al. Cutting edge: dissociation between autoimmune response and clinical disease after vaccination with dendritic cells. J Immunol 2003;170:24-27.
147. Martin F, Kearney JF. B1 cells: similarities and differences with other B cell subsets. Curr Opin Immunol 2001;13:195-201.
148. Martin F, Oliver AM, Kearney JF. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001;14:617-629.